Skip to main content
OpenTrials
Completed

NCT Number: NCT03302702

Duration of Exercise Program in Interstitial Lung Diseases.

We aimed to compare the functional results of the 8th week with the results of the 12th week of the exercise programs applied to the patients with ILD.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Interstitial Lung Disease Behavior Lung Diseases Lung Diseases, Interstitial Motor Activity Respiratory Tract Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Exercise programs (EP) have been shown to be the effective approach for functional outcomes in interstitial lung diseases (ILD). In many studies, the duration of exercise programs varies between 8-12 weeks. However, the optimal duration of exercise program is still unknown.

We aimed to compare the results of the 8th week with the results of the 12th week of the PR programs applied to the patients with ILD.

A total of 14 patients with ILD referred to our PR unit [11 idiopathic pulmonary fibrosis, 2 sarcoidosis (stage 3 and 4) and 1 nonspecific interstitial pneumonia] were included in the study. Pulmonary function test, arterial blood gas analysis, 6- minute walk test, mMRC dyspnea scale, quality of life questionnaires and hospital anxiety depression scale were performed before, at the 8th and 12th weeks after the exercise program applied to the patients twice a week.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Completed the 12 week exercise program
  • Diagnosed with ILD

Exclusion criteria

  • Not completed 12 week exercise program

Treatment and study plan

exercise program

Other

Exercise program including breathing control, pursed-lip breathing, diaphragmatic and thoracic breathing, aerobic and strengthening training

Primary outcomes

  1. Six minute walk test

    Time frame: 6 minute

    It was performed in a 30-meter long corridor in accordance with American Thoracic Society criteria

Secondary outcomes

  1. mMRC

    Time frame: 5 minutes

    It was used for dyspnea that patients felt during their daily activities.

  2. Pulmonary Function Test

    Time frame: 20 minutes

    It was used for assessment of lung functions

  3. SGRQ

    Time frame: 30 minutes

    A disease-specific quality of life scale

  4. SF-36 Health Survey

    Time frame: 30 minutes

    A health related quality of life scale

  5. Hospital Anxiety and Depression Inventory

    Time frame: 20 minutes

    It was used for assessment of anxiety and depression

Sponsors and collaborators

Lead sponsor

Izmir Katip Celebi University

Other

Registry information

Official study title

A Comparison Trial of Eight Weeks Versus Twelve Weeks of Exercise Program in Interstitial Lung Diseases.

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Oct 5, 2017
Registry last updated
Oct 5, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.